Khaltaev N, Axelrod S. Global lung cancer mortality trends and lifestyle modifications: preliminary analysis. Chin Med J (Engl). 2020;133(13):1526–32.

Article  PubMed  Google Scholar 

Li C, Chen Q, Tian Y, et al. 68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression. J Nucl Med. 2024;65(4):527–32.

Article  CAS  PubMed  Google Scholar 

Röhrich M, Daum J, Gutjahr E, et al. Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions. J Nucl Med. 2024;65, 6:872-879.

Ceylan N, Doğan S, Kocaçelebi K, Savaş R, Çakan A, Çağrici U. Contrast enhanced CT versus integrated PET-CT in pre-operative nodal staging of non-small cell lung cancer. Diagn Interv Radiol. 2012;18(5):435–40.

PubMed  Google Scholar 

Archer JM, Truong MT, Shroff GS, Godoy MCB, Marom EM. Imaging of Lung Cancer Staging. Semin Respir Crit Care Med. 2022;43(6):862–73.

Article  PubMed  Google Scholar 

Zhi XY, Yu JM, Shi YK. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version) [published correction appears in Cancer. 2016 Jan 1;122(1):162]. Cancer. 2015;121

Grgic A, Yüksel Y, Gröschel A, et al. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging. 2010;37(6):1087–94.

Article  PubMed  Google Scholar 

Kligerman S, Digumarthy S. Staging of non–small cell lung cancer using integrated PET/CT. Am J Roentgenol. 2009;193(5):1203–11.

Article  Google Scholar 

Liu J, Dong M, Sun X, Li W, Xing L, Yu J. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. PLoS One. 2016;11, 1.

Li H, Li L, Liu Y, Deng Y, Zhu Y, Huang L, Long T, Zeng L, Shu Y, Peng D. Predictive value of CT and 18F-FDG PET/CT features on spread through air space in lung adenocarcinoma. BMC Cancer. 2024Apr 8;24(1):434.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Endoh H, Ichikawa A, Yamamoto R, et al. Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer. Int J Clin Oncol. 2021;26(1):87–94.

Article  CAS  PubMed  Google Scholar 

Ravikanth R. Unilateral vocal cord paralysis secondary to central bronchogenic carcinoma. Indian J Med Paediatr Oncol. 2018;39:91–2.

Article  Google Scholar 

Ruiter J, de Langen A, Monkhorst K, et al. Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer. Acta Chir Belg. Published online February 28, 2024.

Farsad M. FDG PET/CT in the Staging of Lung Cancer. Curr Radiopharm. 2020;13(3):195–203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarswat S, Khan D, Sagar S, Kumar R. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus. Nucl Med Commun. 2023;44, 8:726–731.

Chassagnon G, Vakalopoulou M, Paragios N, et al. Artifcial intelligence applications for thoracic imaging. Eur J Radiol. 2020;123:108774.

Article  PubMed  Google Scholar 

Zhao H, Su Y, Lyu Z, Tian L, Xu P, Lin L, Han W, Fu P. Non-invasively Discriminating the Pathological Subtypes of Non-small Cell Lung Cancer with Pretreatment 18F-FDG PET/CT Using Deep Learning. Acad Radiol 2024;31(1):35–45.

Beer L, Hochmair M, Haug AR, Schwabel B, Kifjak D, Wadsak W, vd. Comparison of RECIST, iRECIST, and PERCIST for the Evaluation of Response to PD-1/PD-L1 Blockade Therapy in Patients With Non–Small Cell Lung Cancer. Clin Nucl Med [Internet]. 2019;44, 7:535.